| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 10/01/2009 | CA2719577A1 Use of ferritin to treat iron deficiency disorders |
| 10/01/2009 | CA2719394A1 Hydroxyquinoxalinecarboxamide derivative |
| 09/30/2009 | EP2105436A1 Lactam-containing compounds and derivatives thereof as factor XA inhibitors |
| 09/30/2009 | EP2105136A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2105135A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2104499A1 Method and composition for reducing reperfusion injury |
| 09/30/2009 | EP2104497A2 Urea and sulfamide derivatives as tafia inhibitors |
| 09/30/2009 | EP1581523B1 Pyrazole-derivatives as factor xa inhibitors |
| 09/30/2009 | EP1453525B1 Selective targeting of apoptotic cells |
| 09/30/2009 | EP1286689B1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 09/30/2009 | CN101544693A Recombined extrasin alpha 1 two-strand body protein and preparation method thereof |
| 09/30/2009 | CN101544614A Phosphodiesterase III inhibitor, method for preparing same and medicinal application thereof |
| 09/30/2009 | CN101543626A Medicament for preventing and curing thrombus and preparation method thereof |
| 09/30/2009 | CN101543571A Rhizoma paridis total aglycone sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543569A Donkey-hide glue nourishing ointment and preparing method thereof |
| 09/30/2009 | CN101543567A Chinese medicinal preparation for treating cerebral thrombosis |
| 09/30/2009 | CN101543549A Chinese lizardtail flavone dripping pill |
| 09/30/2009 | CN101543548A Chinese lizardtail flavone quick release preparation |
| 09/30/2009 | CN101543529A Clinopodium polycephalum total aglycone sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543528A Clinopodium polycephalum total aglycone oral pharmaceutical preparation as well as preparation method and application thereof |
| 09/30/2009 | CN101543526A Kudzu root total aglycone sustained-release pellet as well as preparation method and application thereof |
| 09/30/2009 | CN101543512A Method for producing dry earthworm powder |
| 09/30/2009 | CN101543481A Double-layer breviscapine sustained-release tablet and preparation method thereof |
| 09/30/2009 | CN101543298A Rutin chewing agent and method for preparing same |
| 09/30/2009 | CN100545160C Diamine derivatives |
| 09/30/2009 | CN100544709C Oral dispersible pharmaceutical composition of an antithrombotic compound |
| 09/29/2009 | US7595394 Porphyrin compound, albumin inclusion compound thereof and artificial oxygen carrier |
| 09/29/2009 | US7595316 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |
| 09/29/2009 | CA2458474C Zwitterionic lipid compound and uses thereof |
| 09/29/2009 | CA2457944C Polycyclic guanine phosphodiesterase v inhibitors |
| 09/29/2009 | CA2404163C Production of recombinant blood clotting factors in human cell lines |
| 09/29/2009 | CA2349330C Nitrogen containing heterobicycles as factor xa inhibitors |
| 09/29/2009 | CA2348391C Chromenone and chromanone derivatives as integrin inhibitors |
| 09/29/2009 | CA2319701C Method of promoting erythropoiesis |
| 09/24/2009 | WO2009117669A2 Treatment with opioid antagonists and mtor inhibitors |
| 09/24/2009 | WO2009117269A1 Substituted 4-hydroxypyrimidine-5-carboxamides |
| 09/24/2009 | WO2009117144A1 Benzazepine compounds |
| 09/24/2009 | WO2009115609A1 The calcium sensor STIM1 and the platelet SOC channel Orai1 (CRACM1) are essential for pathological thrombus formation |
| 09/24/2009 | WO2009063028A3 Substituted amides, manufacturing and use thereof as medicaments |
| 09/24/2009 | WO2009061852A3 Modulation of factor 9 expression |
| 09/24/2009 | WO2008151288A3 Aromatic and heteroaromatic compounds useful in treating iron disorders |
| 09/24/2009 | US20090240031 Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments |
| 09/24/2009 | US20090239879 N-oxides of n-phenyl-2-pyrimidine-amine derivatives |
| 09/24/2009 | US20090239857 Triamine derivative |
| 09/24/2009 | US20090239839 Receptor antagonist |
| 09/24/2009 | US20090238826 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage |
| 09/24/2009 | US20090238803 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 09/24/2009 | CA2719134A1 Treatment with opioid antagonists and mtor inhibitors |
| 09/24/2009 | CA2718749A1 The calcium sensor stim1 and the platelet soc channel orai1 (cracm1) are essential for pathological thrombus formation |
| 09/24/2009 | CA2718528A1 Substituted 4-hydroxypyrimidine-5-carboxamides |
| 09/24/2009 | CA2718081A1 Von willebrand factor specific binders and methods of use therefor |
| 09/23/2009 | EP2103630A1 Preparation of low bleeding anticoagulant fusion protein and its use |
| 09/23/2009 | EP2103613A1 Quinoxaline derivative |
| 09/23/2009 | EP2103607A1 1-phenyl 1-thio-d-glucitol derivative |
| 09/23/2009 | EP2103598A1 Fluorinated cycloalkyl-derived benzoylguanidine, method for producing same, use of same as medicine and medicine containing same |
| 09/23/2009 | EP2103311A1 The calcium sensor STIM1 is essential for pathological thrombus formation |
| 09/23/2009 | EP2102189A2 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 09/23/2009 | EP2102176A2 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 09/23/2009 | EP2102168A1 Acylaminopyrazoles for treating cardiovascular diseases |
| 09/23/2009 | EP2101821A1 Factor viia- (poly) sialic acid conjugate having prolonged in vivo half-life |
| 09/23/2009 | EP2101795A2 Cellular preparations for use as a revascularisation stimulating agent |
| 09/23/2009 | EP2101794A2 Inorganic solids that accelerate coagulation of blood |
| 09/23/2009 | EP2101760A2 Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor |
| 09/23/2009 | EP1621207B1 Mixture of defibrotide and G-CSF, and its use for activating haematopoietic progenitors |
| 09/23/2009 | EP1508561B1 2-(a-HYDROXYPENTYL) BENZOATE AND ITS PREPARATION AND USE |
| 09/23/2009 | EP1482928B1 Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 09/23/2009 | EP0946508B1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 09/23/2009 | CN101541379A Methods for modulating apoptosis in platelets |
| 09/23/2009 | CN101538557A Recombinant human divalent metal ion transporter adenovirusm and preparation method and application thereof |
| 09/23/2009 | CN101538320A Artificial zinc finger protein transcription factor capable of specifically regulating up HO-1 gene expression and application thereof |
| 09/23/2009 | CN101538316A Method for preparing Eptifibatide with solid phase method |
| 09/23/2009 | CN101538314A Method for purifying Eptifibatide |
| 09/23/2009 | CN101538313A Peptide-based compounds |
| 09/23/2009 | CN101538299A Method for synthesizing 5,6,4'-trihydroxyflavone-7-O-D-glucuronic acid |
| 09/23/2009 | CN101538296A Active ingredients of camptosorus sibiricus, and extraction method and use of same |
| 09/23/2009 | CN101537191A Recomposed tPA gene-chitosan nanoparticle complex and preparation method thereof |
| 09/23/2009 | CN101537190A Peptide-based compounds |
| 09/23/2009 | CN101537177A Drug with thrombus-curing function and preparation method thereof |
| 09/23/2009 | CN101537154A Manufacturing method of medicament for treating ten kinds of diseases |
| 09/23/2009 | CN101537134A Chinese traditional medicine preparation for curing ascites due to cirrhosis |
| 09/23/2009 | CN101537130A Chinese traditional medicine preparation for curing hypertensive cerebral hemorrhage |
| 09/23/2009 | CN101537094A Chinese medicine hemostatic powder |
| 09/23/2009 | CN101537048A Application of buckwheat and bee pollen in preparing drugs and method for preparing capsules and tablets thereby |
| 09/23/2009 | CN101537026A Xuesaitong dispersible tablet and preparation method thereof |
| 09/23/2009 | CN101536988A Troxerutin freeze-dried powder injection and preparation method thereof |
| 09/23/2009 | CN101536854A Health-caring process quilt |
| 09/23/2009 | CN101536715A Orange peel tea bag |
| 09/23/2009 | CN100542568C Medicine for refreshing brain and nourishing blood |
| 09/23/2009 | CN100542550C Fresh motherwort juice-oral liquid preparing method |
| 09/23/2009 | CN100542530C 3'- (2z)- 1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy- 1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 09/22/2009 | US7592455 potent and selective inhibitors of p38 kinase, especially p38 alpha , p38 beta and p38 beta 2; immune or inflammatory disorders; Ethyl 3-(benzylamino)-6-oxo-7-phenyl-6,7-dihydrothieno[2,3-b]pyridine-2-carboxylate |
| 09/22/2009 | US7592339 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/22/2009 | US7592331 2-(1-Amino-isoquinolin-6-ylamino)-4,11-diazatricyclo[14.2.2.1(6,10)]henicosa-1(19),6,8,10(21),16(20),17-hexaene-3,12-dione trifluoroacetic acid salt; serine protease inhibitors; arterial cardiovascular thromboembolic disorders; cerebral, kidney, pulmonary embolisms; acute coronary syndrome;prosthetics |
| 09/22/2009 | US7592305 Use of ghrelin for treating malnutrition in gastrectomized individuals |
| 09/22/2009 | US7592134 Viral reduction method for plasma using a leukocyte-reduction filter and two virus-reduction filters of decreasing pore diameters |
| 09/22/2009 | US7592010 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 09/22/2009 | US7591949 Method for the improvement of transport across adaptable semi-permeable barriers |
| 09/22/2009 | CA2353727C Use of amtolmetin guacyl for the production of anti-inflammatory drugs for intestinal inflammations |
| 09/17/2009 | WO2009114677A1 Pyridazine derivatives as factor xia inhibitors |
| 09/17/2009 | WO2009114090A2 Method for inhibiting the build-up of arterial plaque by administering fullerenes |